EGFR and non-small cell lung carcinoma: Among 35 tumors obtained from patients with EGFR-mutated NSCLC treated with EGFR-TKIs, the present tumor showed relatively increased inflammatory cells, including exhausted CD4 and CD8 positive cells and M1-like macrophages, compared to other tumors (Figure 3).